Healthcare provider profile · identity verified

Thomas A Craig, MD

Internal Medicine · JUNCTION CITY, KS · NPI 1023054715

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	363	89
Losartan Potassium	Losartan Potassium	276	68
Furosemide	Furosemide	268	72
Levothyroxine Sodium	Levothyroxine Sodium	266	58
Gabapentin	Gabapentin	250	49
Amlodipine Besylate	Amlodipine Besylate	244	58
Lisinopril	Lisinopril	182	44
Pantoprazole Sodium	Pantoprazole Sodium	178	41
Eliquis	Apixaban	172	32
Omeprazole	Omeprazole	159	48
Potassium Chloride	Potassium Chloride	153	51
Simvastatin	Simvastatin	141	28
Oxycodone Hcl	Oxycodone Hcl	139	25
Metoprolol Succinate	Metoprolol Succinate	134	34
Sertraline Hcl	Sertraline Hcl	120	29
Metformin Hcl	Metformin Hcl	118	25
Albuterol Sulfate Hfa	Albuterol Sulfate	117	29
Zolpidem Tartrate	Zolpidem Tartrate	114	17
Allopurinol	Allopurinol	112	27
Rosuvastatin Calcium	Rosuvastatin Calcium	110	35
Carvedilol	Carvedilol	102	26
Tamsulosin Hcl	Tamsulosin Hcl	95	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	91	19
Lorazepam	Lorazepam	90	19
Hydrochlorothiazide	Hydrochlorothiazide	88	22
Meloxicam	Meloxicam	77	18
Clonazepam	Clonazepam	74	14
Clopidogrel	Clopidogrel Bisulfate	66	18
Alendronate Sodium	Alendronate Sodium	64	21
Fluticasone Propionate	Fluticasone Propionate	64	17
Warfarin Sodium	Warfarin Sodium	64	14
Jardiance	Empagliflozin	63	14
Pravastatin Sodium	Pravastatin Sodium	63	12
Spironolactone	Spironolactone	62	15
Metformin Hcl Er	Metformin Hcl	61	19
Glipizide	Glipizide	60	14
Tramadol Hcl	Tramadol Hcl	60	19
Carbamazepine	Carbamazepine	59	suppressed
Duloxetine Hcl	Duloxetine Hcl	59	11
Chlorthalidone	Chlorthalidone	58	16
Temazepam	Temazepam	52	11
Quetiapine Fumarate	Quetiapine Fumarate	51	suppressed
Famotidine	Famotidine	45	suppressed
Trazodone Hcl	Trazodone Hcl	44	12
Finasteride	Finasteride	43	11
Levetiracetam	Levetiracetam	41	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	41	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Clonidine Hcl	Clonidine Hcl	36	suppressed
Doxepin Hcl	Doxepin Hcl	36	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	35	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Novolog Flexpen	Insulin Aspart	33	13
Prednisone	Prednisone	33	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	11
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Ozempic	Semaglutide	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	12
Glipizide Er	Glipizide	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Telmisartan	Telmisartan	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Cephalexin	Cephalexin	22	19
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Fluconazole	Fluconazole	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Ramipril	Ramipril	21	suppressed
Haloperidol	Haloperidol	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Digoxin	Digoxin	19	suppressed
Colchicine	Colchicine	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Naloxone Hcl	Naloxone Hcl	17	17
Trulicity	Dulaglutide	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Nitroglycerin	Nitroglycerin	14	suppressed
Torsemide	Torsemide	14	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Atenolol	Atenolol	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Baclofen	Baclofen	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Estradiol	Estradiol	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error